Wei Yee Chan

10PUBLICATIONS
63CO-AUTHORS
Haematological tumoursMedical infection agents (incl. prions)Medical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 12, 2026
RNA terminal uridylyl transferases are druggable vulnerabilities in AML but are dispensable for normal hematopoiesis.

|Jul 19, 2026
Real-world outcomes of triplet therapy with gilteritinib, azacitidine and venetoclax in FMS-like tyrosine kinase 3 (FLT3)-mutated relapsed/refractory acute myeloid leukaemia: A UK single-centre experience.

|Jan 19, 2024
Budding yeast as an ideal model for elucidating the role of N6-methyladenosine in regulating gene expression.

Waleed S Albihlal, Wei Yee Chan, Folkert J van Werven

|Aug 30, 2023
Molecular MRD is strongly prognostic in patients with NPM1-mutated AML receiving venetoclax-based nonintensive therapy.

Jad Othman, Ing S Tiong, Jenny O'Nions

Pageof 2

Frequent Collaborators

4 joint publications

Ke Xu

3 joint publications

Kwee L Yong

2 joint publications

Louise Ainley

2 joint publications

Elspeth M Payne